Alkem Laboratories Limited — Board Meeting, 13-11-2025: Outcome of Board Meeting
13-11-2025 | 01:48 pm
13-11-2025 | 01:48 pm
ALKEM's board approved consolidated financial results: Q2 revenue ₹4,001 Cr (profit ₹765 Cr), H1 revenue ₹7,372 Cr (profit ₹1,429 Cr). Results include a ₹14.3 Cr exceptional gain from an Indore facility sale.
No comments yet. Be the first to comment!
